Archive: 2026/02 - Page 2
How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
Paragraph IV certification under the Hatch-Waxman Act lets generic drug makers challenge brand patents to speed up affordable drug access. Learn how the legal process works, why it succeeds or fails, and its impact on drug prices.
read more